icahn supports move to sell medimmune medimmune inc shareholder carl icahn said he no longer intends to put up an opposition slate to the board now that medimmune said it is pursuing a possible sale of the drug company the billionaire investor said he reserves the right to launch a proxy contest if the company doesnt successfully complete the sale transaction last week the gaithersburg md company said it was exploring a possible sale after "indications of interest by major pharmaceutical companies " as well as "dissatisfaction with the companys short term stock price performance" among some investors speculation of a medimmune sale grew in february after mr icahns money management group disclosed it owned million shares of the company 
